GL1X · GenesisL1 explorer

MolNFT v1 · #84708 · protein

Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by fragment screening and structure based drug design

3ZSX: “Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by fragment screening and…”. X-ray diffraction, 2 ligands (N44, SO4), 7 pockets (best druggability 0.64). MolNFT v1 #84708 on GenesisL1: 3D structure…

PDB
3ZSX
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.-
UniProt
Q76353
Ligands
N44, SO4
Pockets
7 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BIntegrase (EC 2.7.7.-)protein14953% helix, 21% strandQ76353

Ligands and binding sites

  • N44 · 5-({[2-(benzylcarbamoyl)benzyl](prop-2-en-1-yl)amino}methyl)-1,3-benzodioxole-4-carboxylate · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12370.640.8228SO4, ACT
2850.470.8120EDO
3960.460.8022EDO
41140.460.7817N44
51620.450.7634empty

Interfaces

1 interface between chains.

  • A–B · 1500 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 3ZSX · Small molecule inhibitors of the LEDGF site of HIV type 1 integrase identified by… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.